OC
DMTK

Oppenheimer & Co’s DermTech, Inc. Common Stock DMTK Stock Holding History

Oppenheimer & Co’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$7.02K – 1537
2024
Q1 		$7.02K Hold
10,000
– – ﹤0.01% 1436
2023
Q4 		$17.5K Sell
10,000
-25,115
-72% -$36.7K ﹤0.01% 1373
2023
Q3 		$50.6K Sell
35,115
-32
-0.1% -$80 ﹤0.01% 1342
2023
Q2 		$91.4K Sell
35,147
-148
-0.4% -$443 ﹤0.01% 1357
2023
Q1 		$130K Buy
35,295
+25,295
+253% +$107K ﹤0.01% 1307
2022
Q4 		$17.7K Buy
+10,000
New +$26.6K ﹤0.01% 1336
2021
Q3 		– Sell
-8,366
Closed -$348K – 1596
2021
Q2 		$348K Sell
8,366
-2,196
-21% -$90.2K 0.01% 1181
2021
Q1 		$536K Buy
+10,562
New +$552K 0.01% 934

Other funds holding DMTK

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

Oppenheimer & Co's DMTK Position: Q2 2024 in Review

Oppenheimer & Co sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 10,000 shares — an estimated $7.02K sold.

Oppenheimer & Co first reported a position in DMTK in Q1 2021 and held it in 8 quarters. The position peaked at $536K in Q1 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Oppenheimer & Co reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Oppenheimer & Co sold 10,000 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $7.02K.
  • Oppenheimer & Co first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Oppenheimer & Co's DermTech, Inc. Common Stock position peaked at $536K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Oppenheimer & Co's 13F filing for Q2 2024, filed 8 Aug 2024.